Priority Jewels's ₹91.50 crore initial public offering (IPO) entered its final day of public subscription today, September 1, 2026, with a price band of ₹190 to ₹200 per share. As of 10:15 A.M on the third day of bidding, the issue had been subscribed 26.03 times.
The basis of allotment is expected to be finalised on September 2, 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on September 4, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
28 August 2026 |
|
Subscription Closing Date |
1 September 2026 |
|
Basis of Allotment Date |
2 September 2026 |
|
Refund Initiation Date |
3 September 2026 |
|
Credit of Shares |
3 September 2026 |
|
Listing on BSE and NSE |
4 September 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[September 1, 2026, 10:15 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.61x |
|
Non-Institutional Investors (NIIs) |
39.26x |
|
Retail Individual Investors (RIIs) |
34.89x |
|
Total |
26.03x |
The company intends to utilise the net proceeds from the fresh issue towards:
Priority Jewels Limited is a designer, manufacturer, and supplier of lightweight diamond-studded gold and platinum jewellery. Incorporated in 2007, the company serves independent jewellers, organised retail chains, and customers in select international markets.
Its product portfolio includes rings, earrings, pendants, necklaces, bracelets, and other lightweight jewellery for everyday wear and special occasions, along with customised lab-grown diamond jewellery. The company focuses on contemporary designs and efficient manufacturing to deliver affordable fine jewellery.
|
Particulars |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
538.95 |
435.49 |
410.51
|
|
EBITDA |
33.62 |
24.28 |
19.35 |
|
Profit After Tax (PAT) |
17.65 |
10.51 |
7.14 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here